An adaptive clinical trial design to identify the target dose of tenecteplase for treatment of acute pulmonary embolism.
An adaptive clinical trial design to identify the target dose of tenecteplase for treatment of acute pulmonary embolism. Clin Trials. 2022 Dec; 19(6):636-646.